Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 2
2006 5
2007 4
2008 2
2010 1
2011 2
2012 3
2013 8
2014 2
2015 4
2016 6
2017 10
2018 9
2019 17
2020 15
2021 20
2022 25
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the EGFR signalling pathway in metastatic colorectal cancer.
Napolitano S, Martini G, Ciardiello D, Del Tufo S, Martinelli E, Troiani T, Ciardiello F. Napolitano S, et al. Among authors: troiani t. Lancet Gastroenterol Hepatol. 2024 Apr 29:S2468-1253(23)00479-X. doi: 10.1016/S2468-1253(23)00479-X. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38697174 Review.
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
De Rosa C, Iommelli F, De Rosa V, Ercolano G, Sodano F, Tuccillo C, Amato L, Tirino V, Ariano A, Cimmino F, di Guida G, Filosa G, di Liello A, Ciardiello D, Martinelli E, Troiani T, Napolitano S, Martini G, Ciardiello F, Papaccio F, Morgillo F, Della Corte CM. De Rosa C, et al. Among authors: troiani t. Biomedicines. 2024 Apr 5;12(4):809. doi: 10.3390/biomedicines12040809. Biomedicines. 2024. PMID: 38672164 Free PMC article.
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of "difficult to treat" non melanoma skin cancer.
Gagliardi F, Russo A, Scharf C, Pinto A, Faenza M, D'Ippolito E, Argenziano G, Troiani T, Reginelli A, Nardone V. Gagliardi F, et al. Among authors: troiani t. Clin Transl Radiat Oncol. 2024 Mar 30;46:100774. doi: 10.1016/j.ctro.2024.100774. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38596818 Free PMC article.
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
Ciardiello D, Martinelli E, Troiani T, Mauri G, Rossini D, Martini G, Napolitano S, Famiglietti V, Del Tufo S, Masi G, Santini D, Avallone A, Pietrantonio F, Lonardi S, Di Maio M, Zampino MG, Fazio N, Bardelli A, Siena S, Cremolini C, Sartore-Bianchi A, Ciardiello F. Ciardiello D, et al. Among authors: troiani t. JAMA Netw Open. 2024 Apr 1;7(4):e245635. doi: 10.1001/jamanetworkopen.2024.5635. JAMA Netw Open. 2024. PMID: 38592721 Free PMC article. Clinical Trial.
The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma.
Brancaccio G, Briatico G, Scharf C, Colella G, Docimo G, Docimo L, Faenza M, Iovino F, Tolone S, Verolino P, Napolitano S, Troiani T, Ronchi A, Franco R, Argenziano G. Brancaccio G, et al. Among authors: troiani t. Dermatol Pract Concept. 2024 Jan 1;14(1):e2024038. doi: 10.5826/dpc.1401a38. Dermatol Pract Concept. 2024. PMID: 38236993 Free PMC article. Review.
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.
Moscarella E, Di Brizzi EV, Alpi P, Arcelli A, Badellino S, Bossi P, Calzavara-Pinton PG, Di Stefani A, Dika E, Eibenschutz L, Fargnoli MC, Fionda B, Gravina GL, Leonulli BG, Longo C, Lospalluti L, Nardone V, Pimpinelli N, Quaglino P, Queirolo P, Rubegni P, Tagliaferri L, Troiani T, Vavassori A, Argenziano G. Moscarella E, et al. Among authors: troiani t. Br J Dermatol. 2024 Mar 15;190(4):578-579. doi: 10.1093/bjd/ljad495. Br J Dermatol. 2024. PMID: 38092023 No abstract available.
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Quaglino P, Ascierto PA, Consoli F, Queirolo P, Spagnolo F, Morelli MF, Berardi R, Chiarion-Sileni V, Tucci M, Troiani T, Melotti B, Rossi E, Mandala M, Rinaldi G, Marcon IG, Pizzuti M, Del Vecchio M. Quaglino P, et al. Among authors: troiani t. Cancer Manag Res. 2023 Nov 11;15:1271-1281. doi: 10.2147/CMAR.S423970. eCollection 2023. Cancer Manag Res. 2023. PMID: 38027240 Free PMC article.
The broad spectrum of cardiotoxicities from immunotherapies.
Iengo M, Topa E, Cuomo A, Marone G, Poto R, Varricchi G, Cristinziano L, Galdiero MR, Ferrara AL, Loffredo S, Formisano L, Troiani T, Mercurio V, Tocchetti CG. Iengo M, et al. Among authors: troiani t. Front Cardiovasc Med. 2023 Sep 15;10:1259620. doi: 10.3389/fcvm.2023.1259620. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37781307 Free PMC article. No abstract available.
160 results